![]()
|
|
||||||||
J. Biol. Chem., Vol. 265, Issue 3, 1812-1820, 01, 1990
SE Ealick, SA Rule, DC Carter, TJ Greenhough, YS Babu, WJ Cook, J Habash, JR Helliwell, JD Stoeckler and RE Parks Jr
The three-dimensional structure of human erythrocytic purine nucleoside
phosphorylase has been determined at 3.2 A resolution using x-ray
diffraction data. Intensity data were measured using radiation from the
Synchrotron Radiation Source, Daresbury, England, and oscillation film
techniques. Phases were determined by using multiple isomorphous
replacement methods with four heavy-atom derivatives and were improved
using solvent flattening techniques. Purine nucleoside phosphorylase exists
in the crystal as a trimer in which subunits are related by a
crystallographic 3-fold axis. Each subunit contains an eight-stranded mixed
beta-sheet and a five-stranded mixed beta-sheet which join to form a
distorted beta-barrel structure. This core beta-structure is flanked by
seven alpha-helices in a manner that generates a novel folding pattern. The
active site, which was characterized from binding of the substrate analogs
8-iodoguanine and 5'-iodoformycin B, is located near the subunit-subunit
boundary within the trimer and involves seven different segments from one
subunit and an additional short segment from an adjacent subunit. In the
crystal, the phosphate- binding site is probably occupied by a sulfate ion.
The specificity of purine nucleoside phosphorylase for guanine,
hypoxanthine, and their analogs can be explained on the basis of the
arrangement of hydrogen bond donors and acceptors in the active site.
Three-dimensional structure of human erythrocytic purine nucleoside phosphorylase at 3.2 A resolution
Department of Pharmacology, University of Alabama, Birmingham 35294.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Zang, W.-H. Wang, S.-W. Wu, S. E. Ealick, and C. C. Wang Identification of a Subversive Substrate of Trichomonas vaginalis Purine Nucleoside Phosphorylase and the Crystal Structure of the Enzyme-Substrate Complex J. Biol. Chem., June 10, 2005; 280(23): 22318 - 22325. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Hong, W. R. Waud, D. N. Levasseur, T. M. Townes, H. Wen, S. A. McPherson, B. A. Moore, Z. Bebok, P. W. Allan, J. A. Secrist III, et al. Excellent In vivo Bystander Activity of Fludarabine Phosphate against Human Glioma Xenografts that Express the Escherichia coli Purine Nucleoside Phosphorylase Gene Cancer Res., September 15, 2004; 64(18): 6610 - 6615. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Bennett, C. Li, P. W. Allan, W. B. Parker, and S. E. Ealick Structural Basis for Substrate Specificity of Escherichia coli Purine Nucleoside Phosphorylase J. Biol. Chem., November 21, 2003; 278(47): 47110 - 47118. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Appleby, I. I. Mathews, M. Porcelli, G. Cacciapuoti, and S. E. Ealick Three-dimensional Structure of a Hyperthermophilic 5'-Deoxy-5'-methylthioadenosine Phosphorylase from Sulfolobus solfataricus J. Biol. Chem., October 12, 2001; 276(42): 39232 - 39242. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lecoq, I. Belloc, C. Desgranges, M. Konrad, and B. Daignan-Fornier YLR209c Encodes Saccharomyces cerevisiae Purine Nucleoside Phosphorylase J. Bacteriol., August 15, 2001; 183(16): 4910 - 4913. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Kicska, L. Long, H. Hörig, C. Fairchild, P. C. Tyler, R. H. Furneaux, V. L. Schramm, and H. L. Kaufman Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes PNAS, March 29, 2001; (2001) 71050798. [Abstract] [Full Text] |
||||
![]() |
M. Y. Galperin, D. R. Walker, and E. V. Koonin Analogous Enzymes: Independent Inventions in Enzyme Evolution Genome Res., August 1, 1998; 8(8): 779 - 790. [Abstract] [Full Text] |
||||
![]() |
F. F. Snyder, J. P. Jenuth, E. R. Mably, and R. K. Mangat Point mutations at the purine nucleoside phosphorylase locus impair thymocyte differentiation in the mouse PNAS, March 18, 1997; 94(6): 2522 - 2527. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Blundell and N. Srinivasan Symmetry, stability, and dynamics of multidomain and multicomponent protein systems PNAS, December 10, 1996; 93(25): 14243 - 14248. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Komissarov, D. V. Romanova, and V. G. Debabov Complete Inactivation of Escherichia coli Uridine Phosphorylase by Modification of Asp[IMAGE] with Woodward's Reagent K J. Biol. Chem., April 28, 1995; 270(17): 10050 - 10055. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Kicska, L. Long, H. Horig, C. Fairchild, P. C. Tyler, R. H. Furneaux, V. L. Schramm, and H. L. Kaufman Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes PNAS, April 10, 2001; 98(8): 4593 - 4598. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |